Exopolysaccharides from Aspergillus terreus: Production, chemical elucidation and immunoactivity.
Animals
Aspergillus
/ chemistry
Carbon
/ metabolism
Culture Media
/ chemistry
Fermentation
Galactose
/ analogs & derivatives
Gas Chromatography-Mass Spectrometry
Glucose
/ chemistry
Glycogen
/ chemistry
Hydrogen-Ion Concentration
Interleukin-1
/ metabolism
Macrophages
/ metabolism
Macrophages, Peritoneal
/ metabolism
Magnetic Resonance Spectroscopy
Male
Mannans
/ chemistry
Methylation
Mice
Nitric Oxide
/ chemistry
Polysaccharides
/ pharmacology
Spectroscopy, Fourier Transform Infrared
Superoxides
/ metabolism
Temperature
Tumor Necrosis Factor-alpha
/ metabolism
beta-Glucans
/ chemistry
Carbohydrates polymers
Macrophage activation
Optimization
Journal
International journal of biological macromolecules
ISSN: 1879-0003
Titre abrégé: Int J Biol Macromol
Pays: Netherlands
ID NLM: 7909578
Informations de publication
Date de publication:
15 Oct 2019
15 Oct 2019
Historique:
received:
06
06
2019
revised:
15
07
2019
accepted:
05
08
2019
pubmed:
10
8
2019
medline:
19
5
2020
entrez:
10
8
2019
Statut:
ppublish
Résumé
Aspergillus terreus, a fungus commonly used in pharmaceutical industry to produce lovastatin and other secondary metabolites, has been reported to have beneficial biological properties. In this study the exopolysaccharides (AT-EPS) produced by A. terreus were evaluated as potential modulators of certain functions of macrophages. The production parameters for EPS obtained from the liquid culture broth of the studied fungus were optimized using response surface methodology (RSM) and indicated good correlation between the experimental and predicted values. The optimum conditions for AT-EPS extraction included fermentation at 28 °C, pH 8.79, under 98 rpm of agitation, using 2.39% glucose (carbon source) and 0.957% ammonium nitrate (nitrogen source). Under these optimized conditions, AT-EPS production was 1.34 g/L medium. The chemical analyses showed that AT-EPS was composed by mannose (Man; 40.5 mol%), galactose (Gal; 35.2 mol%), and glucose (Glc; 24.3 mol%), and the spectroscopic (FTIR; NMR) and methylation analyses indicated the presence of galactomannans, β-1,3-glucans, and glycogen-like glucans. AT-EPS was tested on murine macrophages to verify its immunoactivity and the treated cells were able to produce nitric oxide, superoxide anion, TNF-α and interleukin 6 similarly to the positive control cells. Furthermore, the macrophages treated with AT-EPS showed activated-like morphological alterations.
Identifiants
pubmed: 31398401
pii: S0141-8130(19)34243-6
doi: 10.1016/j.ijbiomac.2019.08.039
pii:
doi:
Substances chimiques
Culture Media
0
Interleukin-1
0
Mannans
0
Polysaccharides
0
Tumor Necrosis Factor-alpha
0
beta-Glucans
0
Superoxides
11062-77-4
galactomannan
11078-30-1
Nitric Oxide
31C4KY9ESH
Carbon
7440-44-0
Glycogen
9005-79-2
beta-1,3-glucan
9051-97-2
Glucose
IY9XDZ35W2
Galactose
X2RN3Q8DNE
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
654-664Informations de copyright
Copyright © 2019 Elsevier B.V. All rights reserved.